APA (7th ed.) Citation

Melo-Carrillo, A., Schain, A. J., Stratton, J., Strassman, A. M., & Burstein, R. (2020). Fremanezumab and its isotype slow propagation rate and shorten cortical recovery period but do not prevent occurrence of cortical spreading depression in rats with compromised blood-brain barrier. PAIN, 161(5), 1037. https://doi.org/10.1097/j.pain.0000000000001791

Chicago Style (17th ed.) Citation

Melo-Carrillo, Agustin, Aaron J. Schain, Jennifer Stratton, Andrew M. Strassman, and Rami Burstein. "Fremanezumab and Its Isotype Slow Propagation Rate and Shorten Cortical Recovery Period but Do Not Prevent Occurrence of Cortical Spreading Depression in Rats with Compromised Blood-brain Barrier." PAIN 161, no. 5 (2020): 1037. https://doi.org/10.1097/j.pain.0000000000001791.

MLA (9th ed.) Citation

Melo-Carrillo, Agustin, et al. "Fremanezumab and Its Isotype Slow Propagation Rate and Shorten Cortical Recovery Period but Do Not Prevent Occurrence of Cortical Spreading Depression in Rats with Compromised Blood-brain Barrier." PAIN, vol. 161, no. 5, 2020, p. 1037, https://doi.org/10.1097/j.pain.0000000000001791.